Intradermal injection Market Stastical Report 2022, 2028

Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method (Normal Sized Needles, Short Needle {Intradermal Microinjection, Microneedle Arrays, and Tattoo Devices}, and Without Needle {Intradermal Liquid Jet Devices and Ballistic Intradermal Injectors}), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)

  • Report Code : TIPRE00019998
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Buy Now

The intradermal injection market is projected to reach US$ 7,415.70 million by 2028 from US$ 3,513.26 million in 2021 and is expected to register a CAGR of 11.3% from 2021 to 2028.

The World Health Organization (WHO) recognizes waste reduction in healthcare delivery as an important aspect of strengthening health systems. Technological advancements have led to the development of surgical approaches that minimize waste and achieve better results with the available resources. The reusable intradermal devices are among the approaches that result in low waste generation, which has a net positive effect on the productivity of an economy. Along with this, the results of several meta-analyses also demonstrated that the intradermal delivery of drugs is able to reduce the intensity of adverse events, as a comparatively low concentration of the drug is required for achieving the optimum responses. The factors mentioned above indicate the favorable condition for the rapid growth of this segment in the future.

Over the past two decades, there has been an unprecedented surge in the demand for intradermal injections due to rising incidence of various diseases and increasing acceptance of intradermal vaccination and aesthetic procedures. Moreover, the demand for less invasive intradermal devices such as intradermal jet injectors, microinjections, and ballistic intradermal injections is also rising among the population for treatment and diagnostic purposes. As per the data of WHO, tuberculosis is the 13th leading cause of death, and about 10 million cases of TB have been recorded every year, which resulted in the sudden rise in the diagnostic rate of TB during the last decade and acts as one of the leading reason for increasing intradermal injection market size of tuberculin syringes. Moreover, the number of aesthetic procedures is increasing rapidly in North America and Europe.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Intradermal injection Market: Strategic Insights

intradermal-injections-market
Market Size Value inUS$ 3,513.26 Million in 2021
Market Size Value byUS$ 7,415.70 Million by 2028
Growth rateCAGR of 11.3% from 2021 to 2028
Forecast Period2021-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Further, the availability of intradermal Influenza vaccine, hepatitis vaccine, and smallpox vaccine is boosting the intradermal injections market; also, the availability of COVID-19 intradermal vaccine in the clinical pipeline of various companies is expected to further trigger the growth rate of this market. During the past few years, an intense surge in the demand for intradermal vaccines has been observed, and various leading manufacturers have introduced intradermal injection simulators and training models for improving the skills of students and healthcare professionals to minimize the chances of errors. Therefore, the efficacy of intradermal infection is increasing continuously, indicating the bright future of this segment.

Lucrative Regions for Intradermal injection Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Increasing Prevalence of Diseases and Growing Adoption of Intradermal Injections and Aesthetic Procedures to Drive Intradermal Injection Market

The intradermal vaccination helps in reducing the potential dose of antigens, improves the immune response generated by the vaccine, and decreases the anxiety associated with the vaccination. This method can also vaccinate the difficult population group with comorbidities as there are low chances of adverse events compared to conventional vaccination. Moreover, neurotoxins-related aesthetic procedures are the leading segment of local aesthetic procedures, and intradermal injections are mainly used to deliver various neurotoxins and ultimately increase the demand for intradermal injections. The rising prevalence rate of tuberculosis is also expected to promote the growth rate of the intradermal injection market.

Method-Based Insights

Based on method, the intradermal injection market is further segmented into normal-sized needles, short needles, and without needles. The short needles are further subsegmented into intradermal microinjection, microneedle arrays and tattoo devices, while the without needles are subsegmented into intradermal liquid jet injectors, and ballistic intradermal injectors. In 2021, the normal sized needles dominated the market, while the short needle segment is estimated to register the highest CAGR during 2021–2028.

Intradermal injection Market, by Method – 2021 and 2028

medical-device
Intradermal injection Market, by Method – 2021 and 2028
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Application-Based Insights

Based on application, the market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment is estimated to hold the largest share of the market in 2021, while the local aesthetic segment is expected to register the highest CAGR during the forecast period.

Companies operating in the intradermal injection market emphasize on adopting the strategy of product innovations to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Intradermal Injection Market – Segmentation

Based on product type, the intradermal injection market is segmented into normal-sized needles, short needles and without needles. The short needles are further subsegmented into intradermal microinjection, microneedle arrays and tattoo devices, while the without needles are subsegmented into intradermal liquid jet injectors, and ballistic intradermal injectors. Based on Application, the intradermal injection market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. By end-user, the defibrillator market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. By Geography, the intradermal injection market is segmented in North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and the Rest of APAC), Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).

Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices are among the leading companies operating in the intradermal injection market.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Method,, Application, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


Which is the most influencing segment growing in the intradermal injection market report?

The global intradermal injection market based on method is segmented into normal-sized needles, short needles and without needles. In 2021, the normal sized needles segment held the largest share of the market, by method while the short needle segment is expected to witness fastest CAGR during 2021 to 2028, due to its increasing acceptance among the global population.

What is the market value of intradermal injection market based on region?

The global intradermal injection market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North American area holds the largest market for intradermal injection. The United States held the most significant intradermal injection market and is expected to grow due to factors such as the increasing diagnostic rates, intradermal vaccination and cosmetic surgeries while the technological advancements by key players in intradermal injections is also boosting the growth rate in US.
The Asia Pacific region is expected to account for the fastest growth in the intradermal injection market. In Japan, India and South Korea, the market is expected to grow owing to the development of the healthcare systems and proliferating medical tourism.

What are the factors impacting for the intradermal injection market?

Several factors are believed to affect intradermal injection market in the coming years. Factors such as growing adoption of intradermal vaccination, increasing incidence of various communicable and non-communicable diseases and increasing acceptance of aesthetic procedures are driving the market growth. However, risks, complications and dosing limitation associated with intradermal injections are likely to hamper the growth of the market.

Who are the major players in the intradermal injection market?

The intradermal injection market majorly consists of the players such as Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, Hindustan Syringes and Medical Devices and others.

What is intradermal injection?

Intradermal injections are the devices used for delivering the active ingredients to the dermis layer of skin. These devices are mainly used for exerting a local action or minimal systemic action, which is mainly due to the limited presence of blood vessels in the dermis layer. The advantages of intradermal injections such as less pain, reduction in adverse events and accurate dose delivery etc. are mainly responsible for its rising market penetration while innovation in this sectors such as needle free intradermal delivery is expected to increase its adaptation rate at global level.

The List of Companies - Intradermal injection Market

  1. BD
  2. West Pharmaceuticals Services
  3. Terumo Corporation
  4. Nanopass
  5. Pharmajet
  6. Idevax
  7. Ensung Global
  8. Crossject
  9. Cardinal Health
  10. Hindustan Syringes and Medical Devices

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Intradermal injection Market